#EXP00269

General

Accession EXP00269
Activity Formation (3-24h)
Date 2014-04-28
Administration In solution
Model in vitro
Organism Staphylococcus epidermidis
Status Validated
Notes No notes

Peptide

hepcidin 20

ICIFCCGCCHRSKCGMCCKT

Experimental activity

Method Concentration Notes
Crystal violet assay 3.12 uM Clinical isolate SeALE, PIA positive
Crystal violet assay 6.25 uM Clinical isolate SeALE, PIA positive
Crystal violet assay 3.12 uM Clinical isolate Se30, PIA positive
Crystal violet assay 12.5 uM Clinical isolate Se30, PIA positive
Crystal violet assay 3.12 uM Clinical isolate SeNOC, PIA positive
Crystal violet assay 6.25 uM Clinical isolate SeNOC, PIA positive
Crystal violet assay 25 uM Clinical isolate SeNOC, PIA positive
Crystal violet assay 3.12 uM Clinical isolate SEVIC, PIA negative
Crystal violet assay 12.5 uM Clinical isolate SEVIC, PIA negative
Crystal violet assay 50 uM Clinical isolate SEVIC, PIA negative
Crystal violet assay 6.25 uM Clinical isolate SeNEG, PIA negative
Crystal violet assay 12.5 uM Clinical isolate SeNEG, PIA negative
Crystal violet assay 6.25 uM Clinical isolate SeBER, PIA negative
Crystal violet assay 12.5 uM Clinical isolate SeNEG, PIA negative
Crystal violet assay 25 uM Clinical isolate SeNEG, PIA negative
Total countable CFUs 50 uM Clinical isolate SeNEG, PIA negative; 18 h incubation

References

Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains ofStaphylococcus epidermidis

Franca Lisa Brancatisano, Giuseppantonio Maisetta, Mariagrazia Di Luca, Semih Esin, Daria Bottai, Ranieri Bizzarri, Mario Campa, Giovanna Batoni

2014. Biofouling 4:435-446